LakeShore Biopharma Co., Ltd (LSBCF) — Net Asset Quality Index
LakeShore Biopharma Co., Ltd (LSBCF) has a Net Asset Quality Index of 36.5% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.37 Billion minus total liabilities of $867.91 Million yields net assets of $499.75 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read LSBCF total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
LakeShore Biopharma Co., Ltd Net Asset Quality Index Over Time (2021–2025)
This chart shows how LakeShore Biopharma Co., Ltd's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of June 2025, the index stands at 36.5%, representing net assets of $499.75 Million against total assets of $1.37 Billion USD. For live market cap and overall valuation, see LSBCF stock market capitalisation.
Annual Net Asset Quality Index for LakeShore Biopharma Co., Ltd (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for LakeShore Biopharma Co., Ltd from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See LSBCF net assets for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 36.5% | $499.75 Million | $1.37 Billion | $867.91 Million | ▼ -2.1 pp |
| 2024 | 38.7% | $585.21 Million | $1.51 Billion | $927.82 Million | ▼ -3.7 pp |
| 2023 | 42.4% | $728.45 Million | $1.72 Billion | $991.30 Million | ▼ -47.5 pp |
| 2022 | 89.9% | $180.68 Million | $201.03 Million | $20.35 Million | ▲ +66.5 pp |
| 2021 | 23.4% | $21.36K | $91.37K | $70.01K | — |